| 摘要 |
The use of a peptide as a prognostic or diagnostic marker for Alzheimers disease wherein the peptides are selected from the group consisting of : (a) HWESASLL (b) IHWESASL (g) ADSGEGDFLAEGGGVR (d) AD[Sp]GEGDFLAEGGGVR; and (e) DSGEGDFLAEGGGVR Wherein Sp is phosphoserine. Peptides (d) and (e) are claimed separately |
